Dashboard
Manage Tickers

IONS


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

31-analysts-assess-ionis-pharmaceuticals-what-you-need-to-know
31 Analysts Assess Ionis Pharmaceuticals: ...
10/16/2025 20:01:18

morgan-stanley-maintains-overweight-on-ionis-pharmaceuticals-raises-price-target-to-90
Morgan Stanley Maintains Overweight on Ion...
10/16/2025 17:58:07

Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price targ...

needham-maintains-buy-on-ionis-pharmaceuticals-raises-price-target-to-78
Needham Maintains Buy on Ionis Pharmaceuti...
10/08/2025 16:24:20

Needham analyst Joseph Stringer maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price target from $7...

oppenheimer-maintains-outperform-on-ionis-pharmaceuticals-raises-price-target-to-90
Oppenheimer Maintains Outperform on Ionis ...
10/08/2025 15:51:23

Oppenheimer analyst Jay Olson maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Outperform and raises the price target fr...

this-penumbra-analyst-turns-bullish-here-are-top-4-upgrades-for-wednesday
This Penumbra Analyst Turns Bullish; Here ...
10/08/2025 13:34:53

jp-morgan-upgrades-ionis-pharmaceuticals-to-overweight-raises-price-target-to-80
JP Morgan Upgrades Ionis Pharmaceuticals t...
10/08/2025 11:47:34

JP Morgan analyst Jessica Fye upgrades Ionis Pharmaceuticals (NASDAQ:IONS) from Neutral to Overweight and raises the price t...

hc-wainwright--co-reiterates-buy-on-ionis-pharmaceuticals-maintains-95-price-target
HC Wainwright & Co. Reiterates Buy on Ioni...
10/08/2025 10:18:14

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $...

ionis-highlights-transformational-rna-medicines-2b-cash-position-and-two-more-independent-launches-planned-for-2026
Ionis Highlights Transformational RNA Medi...
10/07/2025 11:17:50

Two independent launches underway in less than nine months, with two more on track for 2026 Growing pipeline of wholly owned me...

stifel-maintains-hold-on-ionis-pharmaceuticals-raises-price-target-to-67
Stifel Maintains Hold on Ionis Pharmaceuti...
10/06/2025 12:24:55

Stifel analyst Paul Matteis maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Hold and raises the price target from $43 t...

goldman-sachs-upgrades-ionis-pharmaceuticals-to-neutral-raises-price-target-to-65
Goldman Sachs Upgrades Ionis Pharmaceutica...
09/26/2025 16:59:03

Goldman Sachs analyst Salveen Richter upgrades Ionis Pharmaceuticals (NASDAQ: IONS) from Sell to Neutral and raises the pric...

morgan-stanley-maintains-overweight-on-ionis-pharmaceuticals-raises-price-target-to-86
Morgan Stanley Maintains Overweight on Ion...
09/23/2025 18:03:46

Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price targ...

barclays-maintains-overweight-on-ionis-pharmaceuticals-raises-price-target-to-80
Barclays Maintains Overweight on Ionis Pha...
09/23/2025 13:58:04

Barclays analyst Gena Wang maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price target from ...

guggenheim-maintains-buy-on-ionis-pharmaceuticals-raises-price-target-to-92
Guggenheim Maintains Buy on Ionis Pharmace...
09/23/2025 12:51:32

Guggenheim analyst Debjit Chattopadhyay maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price target...

b-of-a-securities-maintains-buy-on-ionis-pharmaceuticals-raises-price-target-to-83
B of A Securities Maintains Buy on Ionis P...
09/23/2025 12:31:42

B of A Securities analyst Jason Gerberry maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and raises the price targe...

what-analysts-are-saying-about-ionis-pharmaceuticals-stock
What Analysts Are Saying About Ionis Pharm...
09/23/2025 12:02:13

hc-wainwright--co-reiterates-buy-on-ionis-pharmaceuticals-maintains-95-price-target
HC Wainwright & Co. Reiterates Buy on Ioni...
09/23/2025 10:56:42

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $...

ionis-pharmaceuticals-reveals-unprecedented-results-from-rare-neurological-disease-trial
Ionis Pharmaceuticals Reveals 'Unprecedent...
09/22/2025 13:06:58

Ionis reports positive pivotal study results for zilganersen in Alexander disease, showing gait speed benefits and strong safet...

ionis-pharmaceuticals-shares-resume
Ionis Pharmaceuticals Shares Resume
09/22/2025 11:31:21

trading-halt-halt-status-updated-at-72500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:25:...
09/22/2025 11:25:04

ionis-pharmaceuticals-says-topline-results-from-the-pivotal-study-of-zilganersen-for-alexander-disease-showed-statistically-significant-and-clinically-meaningful-stabilization-on-the-primary-endpoint-of-gait-speed-compared-to-control
Ionis Pharmaceuticals Says Topline Results...
09/22/2025 11:07:18

First and only investigational medicine to demonstrate a clinically meaningful and disease-modifying impact on this rare, often...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION